ACTEMRA® (tocilizumab) Treament Information for Rheumatologists - ACTEMRA® (tocilizumab)

NOW FDA APPROVEDfor first-line biologicuse in DMARD-IR patients

For more information aboutACTEMRA Monotherapy
Many biologics work best with MTX, but evidence suggests that certain patients need a different approach to therapy

For more information aboutACTEMRA Monotherapy
Across multiple studies multiple endpoints and multiple patient types, ACTEMRA Monotherapy: Consistent results

To learn about the efficacy of ACTEMRA Monotherapyin DMARD-IR and TNF-IR RA patients

Safety First

Before reading more, please see the important side effect information for ACTEMRA

Button 1 Patient Safety Click to Read More
ACTEMRA Safety Profile

Clinical study safety data

Patient Safety Get Information
REMS Program

Risk Evaluation and Mitigation Strategy

Button 3 Patient Safety Get Information
Dosing and Administration

Dosing Calculator

Button 2 Go to Dosing Calculator

Help Your Patients Access ACTEMRA

Learn how Genentech is committed to helping patients access the treatment they need

Button 4 Co-Pay CardGet Information

X